The independent source for health policy research, polling, and news.
21 - 40 of 210 Results
Technological gaps handicap rural hospitals as billions in federal funding to modernize infrastructure lags. The reliance on outdated technology and piecemeal systems challenge staffs and erode patient care.
From halting diversity programs that benefit disabled workers to making federal staffing cuts, the Trump administration has taken a slew of actions that harm people with disabilities.
The fatal shooting of UnitedHealthcare CEO Brian Thompson prompted both grief and public outrage about the ways insurers deny treatment. Republicans and Democrats agree prior authorization needs fixing, but patients are growing impatient.
Nearly 3 million Americans live sicker, shorter lives in the hundreds of rural counties where doctor shortages are the worst and poor internet connections mean little or no access to telehealth services.
The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market. Patients and scientists say it’s time to push harder for breakthroughs.
The generation that faced discrimination, ostracism, and the AIDS epidemic now faces old age. Many struggle with isolation along with a host of pressing health problems.
The United States has made almost no progress in closing racial health disparities despite promises, research shows. The government, some critics argue, is often the underlying culprit.
As California cities crack down on homeless encampments in the wake of a U.S. Supreme Court ruling authorizing fines and arrests, front-line workers say such sweeps are undercutting billions in state and federal Medicaid spending meant to stabilize people’s health and get them off the streets.
Healthcare in Action, a California medical group that exclusively serves homeless people, has tapped into growing demand and funding for street medicine services. Three years in, the innovative nonprofit is raking in revenue and serving thousands of people who otherwise might flock to the hospital for high-cost care.
Did the price of insulin go down? It’s not quite that simple. On this episode of “An Arm and a Leg,” producer Emily Pisacreta explores recent changes to the cost of the diabetes medication.
Despite the prevalence of autoimmune conditions, like the thyroid disease Hashimoto’s, sometimes finding help can prove frustrating as well as expensive. There are often no definitive diagnostic tests, so patients may rack up big bills as they search for confirmation of their condition and for treatment options.
This illustrated report has been adapted from a KFF Health News article, “Many Autoimmune Disease Patients Struggle With Diagnosis, Costs, Inattentive Care” by Andy Miller, with artwork by Oona Tempest.
The “Diabetes Belt,” as defined by the Centers for Disease Control and Prevention, comprises 644 mostly Southern counties where diabetes rates are high. Of those counties, KFF Health News and NPR found, more than half also have high levels of medical debt.
Gov. Gavin Newsom’s ambitious experiment in health care is supposed to cut costs as it fills the needs of hard-to-reach people. The program’s start is chaotic and limited, but it shows promise.
Millions of Americans suffer from long covid, which can have debilitating physical effects, including fatigue and difficulty breathing. Yet many patients feel they’re on their own.
Persistent fatigue — the feeling of having no energy — can contribute to frailty and affects 40% to 74% of older patients with chronic illness. Yet its causes can be elusive.
KHN gives readers a chance to comment on a recent batch of stories.
Fresh produce prescription programs are getting a boost in Montana as a way of helping people with chronic conditions such as diabetes and high blood pressure. The approach may be a model for other rural states to promote healthy eating in food deserts.
In November, the Centers for Disease Control and Prevention released new guidelines for prescribing opioids for pain, allowing physicians more flexibility. But doctors, patients, and advocates wonder if the updated standards will be too little, too late to help chronic pain patients in a country still focused on fighting the ongoing opioid crisis.
© 2026 KFF